PATRICK GILLETTE: Open Payments
NPI 1083202147 · RALEIGH, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,393 in 71 payments from 18 companies in 2025. Trend: 2023 $3,009 · 2024 $3,005 · 2025 $1,393
Food & beverage: $1,393
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 9 | $187 |
| Collegium Pharmaceutical, Inc. | 9 | $147 |
| Teva Pharmaceuticals USA, Inc. | 9 | $141 |
| Neurocrine BioSciences, Inc. | 6 | $138 |
| Alkermes, Inc. | 5 | $92 |
| Bausch Health US, LLC | 4 | $91 |
| ABBVIE INC. | 4 | $91 |
| Tris Pharma Inc | 4 | $74 |
| Vanda Pharmaceuticals Inc. | 4 | $73 |
| E.R. Squibb & Sons, L.L.C. | 3 | $53 |
Products named: Jornay PM, Auvelity, INGREZZA, ARISTADA, WELLBUTRIN, VRAYLAR, REXULTI, Dyanavel XR.
Industry payments across NC — which companies pay providers there.
